Peptide Database

Browse our library of evidence-based peptide monographs. Each profile covers mechanism of action, pharmacokinetics, dosing protocols, safety data, and clinical evidence with full citations to peer-reviewed literature.

GLP-1 Agonist FDA Approved

Semaglutide

GLP-1 Receptor Agonist

Acylated GLP-1 analog for type 2 diabetes, weight management, and cardiovascular risk reduction.

Subcutaneous Oral
GLP-1/GIP Agonist FDA Approved

Tirzepatide

Dual GIP/GLP-1 Agonist

First-in-class dual incretin agonist for type 2 diabetes and obesity.

Subcutaneous
GLP-1 Agonist FDA Approved

Liraglutide

GLP-1 Receptor Agonist

Acylated GLP-1 analog with albumin binding for daily diabetes and weight management dosing.

Subcutaneous
Melanocortin FDA Approved

PT-141 / Bremelanotide

Melanocortin Agonist

Selective MC3R/MC4R agonist approved for hypoactive sexual desire disorder in premenopausal women.

Subcutaneous
Neuropeptide FDA Approved

Oxytocin

Neuropeptide

Endogenous neuropeptide approved for labor induction, with research in social bonding and anxiety.

Intravenous Intranasal
GHRH Analog FDA Approved

Tesamorelin

GHRH Analog

Synthetic GHRH(1-44) analog approved for HIV-associated lipodystrophy.

Subcutaneous
GHRH Analog Compounded

Sermorelin

GHRH Analog

Synthetic GHRH(1-29) that preserves natural pulsatile GH secretion. Formerly FDA-approved.

Subcutaneous
Thymic Peptide Compounded

Thymosin Alpha-1

Thymic Peptide

Immune modulator approved in 35+ countries for hepatitis and as cancer immunotherapy adjunct.

Subcutaneous
Gastric Pentadecapeptide Research Only

BPC-157

Gastric Pentadecapeptide

Gastric juice-derived peptide studied for tissue repair, GI protection, and anti-inflammatory effects.

Subcutaneous Oral
Thymosin Peptide Research Only

TB-500

Thymosin Peptide

Synthetic thymosin beta-4 fragment promoting cell migration and tissue repair.

Subcutaneous Intramuscular
GHRH + GH Secretagogue Research Only

CJC-1295 / Ipamorelin

GHRH + GH Secretagogue

GHRH analog and selective GH secretagogue combination for growth hormone stimulation.

Subcutaneous
Triple Agonist Research Only

Retatrutide

Triple Agonist (Investigational)

Investigational triple GIP/GLP-1/glucagon agonist with 24.2% weight loss in Phase 2.

Subcutaneous
HGH Fragment Research Only

AOD-9604

HGH Fragment

Modified HGH fragment 176-191 studied for lipolysis without growth-promoting effects.

Subcutaneous
Copper Peptide Research Only

GHK-Cu

Copper Peptide

Naturally occurring tripeptide-copper complex studied for wound healing and skin regeneration.

Topical Subcutaneous
Melanocortin Agonist Research Only

Melanotan II

Melanocortin Agonist

Non-selective melanocortin agonist studied for tanning and sexual function. Significant safety concerns.

Subcutaneous
Tuftsin Analog Research Only

Selank

Tuftsin Analog

Synthetic tuftsin analog with anxiolytic and immunomodulatory properties. Approved in Russia.

Intranasal
ACTH Analog Research Only

Semax

ACTH Analog

Synthetic ACTH(4-10) analog with nootropic and neuroprotective properties. Approved in Russia.

Intranasal
Tetrapeptide Research Only

Epithalon

Tetrapeptide

Synthetic pineal gland peptide studied for telomerase activation and anti-aging.

Subcutaneous
Nonapeptide Research Only

DSIP

Nonapeptide

Delta sleep-inducing peptide studied for sleep modulation and stress protection.

Subcutaneous Intravenous
Antimicrobial Peptide Research Only

LL-37

Antimicrobial Peptide

Endogenous cathelicidin fragment with antimicrobial, immunomodulatory, and wound healing properties.

Subcutaneous
Anti-inflammatory Tripeptide Research Only

KPV

Anti-inflammatory Tripeptide

Alpha-MSH fragment with NF-kB inhibition studied for gut inflammation.

Oral Subcutaneous
Mitochondrial Peptide Research Only

MOTS-c

Mitochondrial Peptide

Mitochondrial-derived peptide activating AMPK with exercise-mimetic properties.

Subcutaneous
Reproductive Peptide Research Only

Kisspeptin-10

Reproductive Peptide

Hypothalamic peptide that stimulates GnRH release. Active fertility research.

Intravenous Subcutaneous
Mitochondrial Peptide Research Only

SS-31 / Elamipretide

Mitochondrial Peptide (Investigational)

Cardiolipin-targeting tetrapeptide in Phase 2/3 trials for mitochondrial diseases.

Subcutaneous
Growth Factor Research Only

IGF-1 LR3

Growth Factor

Modified IGF-1 with extended half-life and reduced binding protein interaction.

Subcutaneous Intramuscular
Growth Factor Research Only

MGF

Growth Factor

IGF-1 splice variant promoting muscle satellite cell proliferation.

Intramuscular
Myostatin Inhibitor Research Only

Follistatin 344

Myostatin Inhibitor

Glycoprotein that binds myostatin and activin A. Gene therapy research for muscular dystrophy.

Subcutaneous
Nootropic Research Only

Dihexa

Nootropic

HGF/c-Met mimetic with potent synaptogenic activity. Very early preclinical. Significant cancer risk concern.

Oral Topical
GH Secretagogue Research Only

GHRP-6

GH Secretagogue

First-generation hexapeptide GH secretagogue. Potent hunger stimulation via ghrelin mimicry.

Subcutaneous
GH Secretagogue Research Only

GHRP-2 / Pralmorelin

GH Secretagogue

Second-generation GH secretagogue. Approved in Japan for GH deficiency diagnosis.

Subcutaneous Intravenous
GH Secretagogue Research Only

Hexarelin

GH Secretagogue

Most potent GHRP for acute GH release. Unique cardioprotective properties via CD36.

Subcutaneous